Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Xolair on Basophil Histamine Release in Ragweed Allergy
NCT00673218Phase 4Unknown
- Sponsor
- Creighton University
- Start
- Jun 2007
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in allergic rhinitis (AR), sponsored by Creighton University. Status: unknown.
02
Drugs
omalizumab
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00673218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673218.